Triad Group (TRD) Share Price, News & Analysis

Company Overview

Triad Group plc provides information technology consultancy services to the public, private, and not-for-profit sectors primarily in the United Kingdom. The company offers consulting and advisory; business insights; software development; project and software delivery; program management; and support services. Triad Group Plc was incorporated in 1988 and is based in Godalming, the United Kingdom.

Key Stats

• Today's Range: 381 to 394
• 50-Day Range: 270 to 410
• 52-Week Range: 176.50 to 410
• Volume: 9,095 shs
• Average Volume: 9,620 shs
• Market Capitalization: £65.68 million
• P/E Ratio: N/A
• Dividend Yield: 1.52%
• Price Target: N/A
• Consensus Rating: N/A

TRD Stock Analysis - Frequently Asked Questions

How have TRD shares performed this year?

Triad Group's stock was trading at GBX 275 at the beginning of the year. Since then, TRD shares have increased by 43.3% and is now trading at GBX 394.
View the best growth stocks for 2025 here.

How were Triad Group's earnings last quarter?

Triad Group plc (LON:TRD) released its earnings results on Thursday, November, 7th. The company reported $4.66 earnings per share for the quarter. Triad Group had a negative net margin of 7.21% and a negative trailing twelve-month return on equity of 28.75%.

How do I buy shares of Triad Group?

Shares of TRD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Triad Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Triad Group investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), AutoZone (AZO), Danaher (DHR), Ovintiv (OVV), Amgen (AMGN) and Atara Biotherapeutics (ATRA).

Company Calendar

• Last Earnings: 11/07/2024
• Ex-Dividend for 12/20 Dividend: 11/21/2024
• Dividend Payable: 12/20/2024
• Today: 3/04/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Computer and Technology
• Industry: Information Technology Services
• Sub-Industry: N/A
• Current Symbol: LON:TRD
• CIK: N/A
• Web: www.triad.co.uk
• Phone: +44-1908-278450
• Fax: N/A
• Employees: 115
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (6.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-1,014,433.19
• Net Margins: -7.21%
• Pretax Margin: N/A
• Return on Equity: -28.75%
• Return on Assets: -10.50%

Debt

• Debt-to-Equity Ratio: 22.15
• Current Ratio: 2.10
• Quick Ratio: 3.17

Sales & Book Value

• Annual Sales: £14.07 million
• Price / Sales: 4.67
• Cash Flow: GBX 111.61 per share
• Price / Cash Flow: 3.53
• Book Value: GBX 20.42 per share
• Price / Book: 19.30

Miscellaneous

• Outstanding Shares: 16,670,400
• Free Float: N/A
• Market Cap: £65.68 million
• Optionable: Not Optionable
• Beta: 1.36